Anti-Caveolin-1 (phospho Y14) antibody [EPR2288Y] - Caveolae Marker
- RabMAb
- Recombinant
- KO Validated
- Lab Essentials
- 20ul selling size
- What is this?
Be the first to review this product! Submit a review
|
(3 Publications)
Rabbit Recombinant Monoclonal Caveolin-1 phospho Y14 antibody. Suitable for Dot, WB and reacts with Synthetic peptide, Human samples. Cited in 3 publications.
View Alternative Names
CAV, CAV1, Caveolin-1
- WB
Lab
Western blot - Anti-Caveolin-1 (phospho Y14) antibody [EPR2288Y] - Caveolae Marker (AB75876)
Blocking/Diluting buffer 5% NFDM/TBST
All lanes:
Western blot - Anti-Caveolin-1 (phospho Y14) antibody [EPR2288Y] - Caveolae Marker (ab75876) at 1/1000 dilution
Lane 1:
Untreated A673 (Human muscle Ewing's Sarcoma) whole cell lysates at 15 µg
Lane 2:
A673 (Human muscle Ewing's Sarcoma) treated with insulin, whole cell lysates at 15 µg
Lane 3:
A673 (Human muscle Ewing's Sarcoma) treated with insulin, whole cell lysates. Then the membrane was incubated with phosphatase. at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 20 kDa
Observed band size: 22 kDa
false
Exposure time: 30s
- WB
Unknown
Western blot - Anti-Caveolin-1 (phospho Y14) antibody [EPR2288Y] - Caveolae Marker (AB75876)
All lanes:
Western blot - Anti-Caveolin-1 (phospho Y14) antibody [EPR2288Y] - Caveolae Marker (ab75876) at 1/2000 dilution
Lane 1:
HeLa cell lysate at 10 µg
Lane 2:
HeLa cell lysate treated with pervanadate at 10 µg
Secondary
All lanes:
Goat anti-rabbit HRP at 1/1000 dilution
Predicted band size: 20 kDa
Observed band size: 22 kDa
false
- Dot
Unknown
Dot Blot - Anti-Caveolin-1 (phospho Y14) antibody [EPR2288Y] - Caveolae Marker (AB75876)
Dot blot analysis of Caveolin-1 (phospho Y14) phospho peptide (Lane 1), Caveolin-1 Non-phospho peptide (Lane 2) labelling Caveolin-1 (phospho Y14) with ab75876 at a dilution of 1/1000. Peroxidase conjugated goat anti-rabbit IgG (H+L)) was used as the secondary antibody at a dilution of 1/2500.
Blocking and diluting buffer : 5% NFDM/TBST.
Exposure time : 3 minutes.
Related conjugates and formulations (1)
-
Anti-Caveolin-1 (phospho Y14) antibody [EPR2288Y] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Caveolae provide a platform for various signaling pathways and involve caveolin-1 as a major component. Caveolin-1 interacts with multiple signaling molecules such as G-protein coupled receptors and Src family kinases to modulate signal transduction. This protein forms part of a larger caveolar complex contributing to cellular processes including endocytosis and lipid regulation. Its presence as a marker in caveolae highlights its significance in cellular functions.
Pathways
Caveolin-1 influences the insulin signaling and nitric oxide (NO) signaling pathways. In the insulin signaling pathway caveolin-1 interacts with insulin receptors to modulate glucose uptake. It also associates with eNOS (endothelial nitric oxide synthase) in the NO signaling pathway impacting vascular function. These relationships highlight its role in cellular communication and regulatory mechanisms within the human body.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
NPJ Parkinson's disease 11:114 PubMed40328804
2025
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 24:496 PubMed35837062
2022
Applications
Unspecified application
Species
Unspecified reactive species
FEBS open bio 11:3115-3125 PubMed34555268
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com